urolithiasis

79
URINARY STONE Urolithiasis Ernie G. Bautista II January 2014 FEU-NRMF School of Medicine

Upload: ernie-g-bautista-ii-rn-md

Post on 19-Jan-2016

45 views

Category:

Documents


4 download

TRANSCRIPT

Page 1: Urolithiasis

URINARY STONEUrolithiasis

Ernie G. Bautista IIJanuary 2014

FEU-NRMFSchool of Medicine

Page 2: Urolithiasis

URINARY STONEUrolithiasis

1. CASE2. REVIEW OF ANATOMY3. CLASSIFICATION OF STONE4. DIAGNOSIS5. TREATMENT6. PREVENTION

Page 3: Urolithiasis

CASE

• 52 y/o, male

• Presented to the ER with severe right flank pain radiating to the RLQ

• BP =154/96, PR = 79 bpm, RR = 24 cpm and T = 36.7° C

Page 4: Urolithiasis

• The pain was insidious in onset and had an intensity of 10/10 on verbal analog scale which decreased to 8/10 after administration of Toradol and Morphine medications provided in the ER.

Page 5: Urolithiasis

• The pain was constant, lasting 3 hours in duration, and he had 2 episodes of emesis since its onset.

• He did not report experiencing any chest pain, dyspnea, fever or bowel and bladder dysfunction.

Page 6: Urolithiasis

• His medical history included a similar pain in the left flank 2 years earlier which was diagnosed as kidney stones.

Page 7: Urolithiasis

Physical Examination

• E/N• He did not display any signs of edema or

nausea, abdominal discomfort or indigestion.

• Abdomen was soft with diffuse tenderness which increased over the RLQ.

• Urinalysis: moderate increase in specific gravity (1.030), significant hematuria (3+) and a trace of protein.

Page 8: Urolithiasis

Diagnostic Imaging

• Abdominal radiograph - right ureteric calculus

• Discharged from the ER with the hope that he would then pass the stone naturally.

Page 9: Urolithiasis

• Unfortunately, the following day, the patient returned reporting that the medications did not significantly affect his pain and his referral to the urology department was expedited.

Page 10: Urolithiasis

• CT scan: – 7mm calcific density in the right

proximal ureter with associated moderate hydronephrosis and perinephric stranding

–Multiple 1–2mm non-obstructing calculi were additionally noted in the left renal parenchyma.

• Diagnosis: right ureteric calculus • Managed with pain

reliever(Ketoroloc, Morphine and Naproxen) and antiemetic medications.

Page 11: Urolithiasis
Page 12: Urolithiasis

• The consulting urologist concluded that because his symptoms were refractory to analgesics, and because the calculus was unlikely to pass on its own, emergency laser lithotripsy was indicated.

• Because his urine appeared murky and was presumed to be infected and the lithotripsy was abandoned.

Page 13: Urolithiasis

• As an alternative, a ureteric stent was placed to help drain the dilated and infected collecting system.

• Antibiotics and Tamsulosin were additionally prescribed.

• The patient was scheduled for stent and calculus removal two months later and instructed to attempt natural passage of the stone during this period.

Page 14: Urolithiasis
Page 15: Urolithiasis

URETER

• Smooth muscle fibers propel urine from the kidneys to the urinary bladder

• 25–30 cm (10–12 in) long • ~3–4 mm in diameter• Histology: transitional epithelium

and an additional smooth muscle layer in the more distal 1/3 to assist with peristalsis.

Page 16: Urolithiasis
Page 17: Urolithiasis

UPJ

UVJ

What are the 3 common sites of obstruction?

Page 18: Urolithiasis

UROLITHIASIS

• Urinary calculus disease

• Obstruction (partial or complete) of the urinary tract by >1 calculi

• Affects 10% of the population over the course of lifetime

Page 19: Urolithiasis

UROLITHIASIS

Page 20: Urolithiasis

CLASSIFICATION OF STONE

• Urinary stones can be classified according to the following aspects: 1. stone size2. stone location3. stone composition (mineralogy)4. x-ray characteristics of stone5. aetiology of stone formation6. risk group for recurrent stone formation

Page 21: Urolithiasis

Stone composition (mineralogy)

Page 22: Urolithiasis

X-ray characteristics of stone

Radiopaque Poor Radiopaque

Radiolucent

•Calcium oxalate dihydrate•Calcium oxalate monohydrate•Calcium phosphates

•Magnesium ammonium phosphate (struvite)•Apatite•Cystine

•Uric acid•Ammonium urate•Xanthine•2,8-dihydroxyadenine•‘Drug-stones’

Page 23: Urolithiasis

Aetiology of stone formation

Non-infection stones• Calcium oxalates• Calcium phosphates• Uric acid

Infection stones• Magnesium-

ammonium-phosphate• Apatite• Ammonium urate

Genetic causes• Cystine*• Xanthine• 2,8-

dihydroxyadenine

‘Drug stones’

Page 24: Urolithiasis
Page 25: Urolithiasis
Page 26: Urolithiasis

High risk stone formersI. General factors• Early onset of urolithiasis in life (especially

children and teenagers)• Familial stone formation• Brushite containing stones (calcium

hydrogen phosphate; CaHPO4 . 2H2O)• Uric acid and urate containing stones• Infection stones• Solitary kidney

Page 27: Urolithiasis

High risk stone formers

II. Diseases associated with stone formation

• Hyperparathyroidism• Nephrocalcinosis• Gastrointestinal diseases or disorders (i.e.

jejuno-ileal bypass, intestinal resection, Crohn’s disease, malabsorptive conditions

• Sarcoidosis

III. Drugs associated with stone formation

Page 28: Urolithiasis

High risk stone formers

IV. Genetically determined stone formation

• Cystinuria (type A, B, AB)• Primary hyperoxaluria (PH)• Renal tubular acidosis (RTA) type I• 2,8-dihydroxyadenine• Xanthinuria• *Lesh-Nyhan-Syndrome (inc. uric acid)• Cystic fibrosis

Page 29: Urolithiasis

High risk stone formers

V. Anatomical and urodynamic abnormalities associated with stone formation

• Medullary sponge kidney (tubular ectasia)• Ureteropelvic junction (UPJ) obstruction• Calyceal diverticulum, calyceal cyst• Ureteral stricture• Vesico-uretero-renal reflux• Horseshoe kidney• Ureterocele• Urinary diversion (via enteric hyperoxaluria)• Neurogenic bladder dysfunction

Page 30: Urolithiasis

DIAGNOSIS

Page 31: Urolithiasis

DIAGNOSIS

I. Medical history and PE• Loin pain, vomiting, and sometimes

fever• Asymptomatic vs SymptomaticII. IMAGING STUDIES• Ultrasonography used as d 1’

procedure

• Non-contrast enhanced CT > intravenous urography (IVU) standard method for diagnosing acute flank pain

Page 32: Urolithiasis

Recommendation

NCCT should be used to confirm a stone diagnosis in patients presenting with acute

flank pain because it is superior to IVU

• Uric acid & xanthine stones – Radiolucent on plain films and can be

detected by NCCT

Page 33: Urolithiasis

DIAGNOSIS

III. Basic AnalysisBLOOD• Serum blood sample– Creatinine, Uric acid, Ionized calcium, sodium,

Potassium

• Blood cell count• CRP• Coagulation test (PTT and INR) - If

intervention is likely or planned

Page 34: Urolithiasis

DIAGNOSIS

III. Basic AnalysisURINE• Urinary sediment/dipstick test out of spot

urine sample– red cells– white cells– nitrite– urine pH level by approximation

• Urine culture or microscopy

Page 35: Urolithiasis

Analysis of Stone Composition• Stone analysis should be performed in all

first-time stone formers.• Repeat stone analysis is needed in case

of:– recurrence under pharmacological

prevention;– early recurrence after interventional therapy

with complete stone clearance;– late recurrence after a prolonged stone-free

period

• Preferred analytical procedures are– X-ray diffraction– Infrared spectroscopy

Page 36: Urolithiasis

1. For renal/ureteral colic2. Sepsis in the obstructed

kidney3. Stone relief

TREATMENT

Page 37: Urolithiasis

For Renal/Ureteral Colic

• 1st choice: treatment should be started with an NSAID–Diclophenac sodium* – Indomethacin– Ibuprofen

• 2nd choice: – Hydromorphine– Pentazocine– Tramadol

Page 38: Urolithiasis

Management of sepsis in the obstructed kidney

• Decompression– placement of an indwelling ureteral catheter

under GA for a period of time– percutaneous placement of a nephrostomy

catheter

• Collect urine following decompression for antibiogram.

• Start antibiotic tx after

Definitive treatment of the stone should be delayed until sepsis is resolved.

Page 39: Urolithiasis
Page 40: Urolithiasis

Stone relief

I. Observation of Kidney StonesII. Medical expulsive therapy (MET)III. Chemolytic dissolution of stonesIV. ESWL (extracorporeal shock wave lit

hotripsy)V. Endourology techniques

I. Percutaneous nephrolitholapaxy (PNL)II. Ureterorenoscopy (including retrograde

access to renal collecting system)

VI.Open and laparoscopic surgery

Page 41: Urolithiasis

Stone relief

I. Observation of Kidney Stones • Ureteral stone < 10 mm and if active

stone removal is not indicated, observation with periodic evaluation is an option for initial treatment.

• May be given medical therapy to facilitate stone passage during the observation period*.–Medical expulsive therapy (MET)

Page 42: Urolithiasis

Likelihood of passage of ureteral stones

Page 43: Urolithiasis

II. Medical expulsive therapy (MET)

• Alpha-blockers (tamsulosin*, doxazosin, terazosin, alfuzosin and naftopidil)

• Calcium-channel blockers (nifedipine)• Alpha-blockers + Corticosteroids

Duration of MET tx: 1 month

Page 44: Urolithiasis

III. Chemolytic dissolution of stones

• Knowledge of stone composition is therefore mandatory prior to chemolysis.

3.1. Percutaneous irrigation chemolysis

3.2. Oral chemolysis

Page 45: Urolithiasis

3.1. Percutaneous irrigation chemolysis

At least 2 nephrostomy catheters should be used to allow irrigation of the renal collecting system, while preventing chemolytic fluid draining into the bladder and reducing the risk of increased intrarenal pressure

Page 46: Urolithiasis

Methods of percutaneous irrigation chemolysis

Page 47: Urolithiasis

3.2. Oral Chemolysis• Efficient ONLY for uric acid calculi.• Tx is based on alkalinisation of the

urine1. alkaline citrate or 2. Na bicarbonate

• pH should be adjusted to b/w 7.0 & 7.2.

Recommendations:• Dipstick monitoring of urine pH .• Compliance.

Page 48: Urolithiasis

IV. ESWL (extracorporeal shock wave lithotripsy)

•Shock wave rate: optimal shock wave frequency is 1.0 Hz•Prospective randomised trials have shown that lowering wave frequency from 120 to 60-90 shock waves/minute improves the stone-free rate, especially in stones >100 mm2

Page 49: Urolithiasis

Extracorporeal shockwave lithotripsy

• Can remove > 90% of stones in adults

• Success rate for ESWL depends on the efficacy of the lithotripter and upon the following factors:– size, location of stone mass (ureteral, pelvic

or calyceal), and composition (hardness) of the stones

– patient’s habitus– performance of ESWL

Page 50: Urolithiasis

Contraindications of ESWL

• Pregnancy• Bleeding diatheses• Uncontrolled urinary tract infections• Severe skeletal malformations and

severe obesity• Arterial aneurysm in the vicinity of the

stone treated• Anatomical obstruction distal of the

stone

Page 51: Urolithiasis

ESWL-related complications

Page 52: Urolithiasis

V. Endourology techniques

A. Percutaneous nephrolitholapaxy (PNL)– a minimally invasive surgical procedure

for the removal of renal (kidney) stones

1. Rigid nephroscopes2. Flexible nephroscopes3. Intracorporeal lithotripsy

Page 53: Urolithiasis

Rigid nephroscopes

Page 54: Urolithiasis

Flexible nephroscopes

Page 55: Urolithiasis

Intracorporeal lithotripsy

• Intracorporal lithotripsy is usually necessary prior to extraction of larger fragments.

• Intracorporeal stone disintegration can be performed in several different ways:– Laser Lithotripsy– Electrohydraulic Lithotripsy– Ballistic Lithotripsy– Ultrasonic Lithotripsy

Page 56: Urolithiasis

Intracorporeal lithotripsyLaser

LithotripsyElectrohydraulic

Lithotripsy (EHL)

Ballistic Lithotripsy

Ultrasonic Lithotripsy

>uses a holmium:YAG laser to vaporize kidney stones

>can fragment all types of kidney stones

>a ureteroscope is first placed. Then, fibers of different sizes can be placed through the endoscope to reach the stone.

>Uses two electrodes to produce a spark that creates a shockwave to break apart the stone

>D/A: potential for damaging adjacent tissue

>Uses a small endoscopic jackhammer to generate energy that uniquely targets inflexible stones

>D/A: requires a rigid lithotriper and a straight ureteroscope.

>First intracorporeal technique

>A rigid probe inserted to the site emits high-frequency sound waves

Page 57: Urolithiasis

Laser Lithotripsy Electrohydraulic Lithotripsy (EHL)

Page 58: Urolithiasis

Pre-operative imaging

• Pre-procedural imaging for PNL, which includes a contrast media study, is mandatory to assess stone comprehensiveness, view the anatomy of the collecting system, and ensure safe access to the kidney stone.

• Ultrasonography or CT of the kidney and the surrounding structures can provide information about interpositioned organs within the planned percutaneous path.

Page 59: Urolithiasis

Positioning of the patient: prone or supine?

• Traditionally, the patient is positioned prone for PNL.

• The supine position is as safe as the prone position.

• Compared with the prone position, the advantages of the supine position for PNL are:– shorter operating time;– possibility of simultaneous retrograde

transurethral manipulation;– more convenient position for the operator;– easier anaesthesia.

Page 60: Urolithiasis

B. Ureterorenoscopy URS(including retrograde access to

renal collecting system)• Instruments– Rigid scopes– Flexible scopes– Digital scopes

• Stones that cannot be extracted directly must first be disintegrated.

• If it is difficult to access stones in need of disintegration within the lower renal pole, it may help to displace the calculi into a more accessible calyx.

Page 61: Urolithiasis

Complications of URS*

Page 62: Urolithiasis

VI. Open and laparoscopic surgery for removal of renal

stones

6.1. Open surgery6.2. Laparoscopic surgery

Page 63: Urolithiasis

Open surgery

• Become a 2nd or 3rd treatment option after ESWL and endourological surgery (i.e. URS and PNL)

• Incidence of open stone surgery– developed countries - 1.5%– developing countries - from 26% to 3.5

%

Page 64: Urolithiasis

Indications for open surgery

1. Concomitant open surgery2. Non-functioning lower pole (partial nephrectomy),

non-functioning kidney (nephrectomy)3. Patient choice following failed minimally invasive

procedures; the patient may prefer a single procedure and avoid the risk of needing more than one PNL procedure

4. Stone in an ectopic kidney where percutaneous access and ESWL may be difficult or impossible

5. For the paediatric population, the same considerations apply as for adults

Page 65: Urolithiasis

Indications for open surgery

6. Complex stone burden7. Treatment failure of ESWL and/or PNL, or failed

ureteroscopic procedure8. Intrarenal anatomical abnormalities: infundibular

stenosis, stone in the calyceal diverticulum (particularly in an anterior calyx), obstruction of the ureteropelvic junction, stricture

9. Morbid obesity10.Skeletal deformity, contractures and fixed

deformities of hips and legs11.Co-morbid medical disease

Page 66: Urolithiasis

Laparoscopic surgery• Laparoscopy is associated with lower

post-operative morbidity, shorter hospital stay and time to convalescence, and better cosmetic results with comparably good functional results

• It can also be an alternative to PNL in the absence of availability (developing countries) or PNL failure and as an adjunct to PNL, especially when access proves difficult (ectopic kidneys).

Page 67: Urolithiasis

Laparoscopic ureterolithotomy

• Although highly effective, it is not a first-line therapy in most cases because of its – invasiveness, – longer recovery time, – and the greater risk of associated

complications compared to ESWL and URS

Page 68: Urolithiasis

Laparoscopic ureterolithotomy

• Indications for laparoscopic kidney-stone surgery include:– Complex stone burden– Failed previous ESWL and/or

endourological procedures– Anatomical abnormalities–Morbid obesity– Nephrectomy in case of non-functioning

kidney

Page 69: Urolithiasis

Laparoscopic ureterolithotomy

• Indications for laparoscopic ureteral stone surgery include:– Large, impacted stones–Multiple ureteral stones– In cases of concurrent conditions

requiring surgery–When other non-invasive or low-invasive

procedures have failed

Page 70: Urolithiasis

Recommendations

• Laparoscopic or open surgical stone removal may be considered in rare cases where ESWL, URS, and percutaneous URS fail or are unlikely to be successful.

• When expertise is available, laparoscopic surgery should be the preferred option before proceeding to open surgery. An exception will be complex renal stone burden and/or stone location.

Page 71: Urolithiasis
Page 72: Urolithiasis
Page 73: Urolithiasis

Recommendation

• Treatment choices should be based on the size and location of the stone and available equipment for stone removal.

Page 74: Urolithiasis

PREVENTION

Page 75: Urolithiasis

THANK YOU!

Page 76: Urolithiasis

MANAGEMENT OF URINARY STONES and RELATED PROBLEMS DURING PREGNANCY

Page 77: Urolithiasis

Diagnostic option

• Ultrasonography is the method of choice in the practical and safe evaluation of a pregnant women.

• In symptomatic patients with suspicion of ureteral stones during pregnancy, limited IVU, MRU, or isotope renography is a useful diagnostic method.

Page 78: Urolithiasis

Management

• If intervention becomes necessary, – placement of a internal stent, – percutaneous nephrostomy, or – ureteroscopy

Page 79: Urolithiasis

Recommendation

• Following the establishment of the correct diagnosis, conservative management should be the firstline treatment for all non-complicated cases of urolithiasis in pregnancy (except those who have clinical indications for intervention)